What I don't understand is this, the company did $129k all of last year, and 1Q $164k, 2nd Q project $200k low end, projects $1.2-$2ml for the year, announced several distribution agreements, demonstrate revenue growth, what is there to bash?
Most R&D companies pile up debt in their first 5 years. Look at US department of commerce statistics, 95% R&D companies fail in the first 5 years, they survived 5 years, the other 5% will survive if they start to generate revenue now they are generating revenue. Those are other fundamentals that the average investor does not consider.
All Sharky, drdroomy and moneyflowmyway and the rest of us are saying is, if we like the stock and the execution of the business plan as we are seeing it unfold today, why allow someone else come in here and kill the stock.
